Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subcutaneous Injection”

924 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 924 results

Testing effectiveness (Phase 2)Looking for participantsNCT03582800
What this trial is testing

Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study

Who this might be right for
Systemic SclerosisDermatomyositisiPPSD2
University Hospital, Limoges 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292
What this trial is testing

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Who this might be right for
Lupus Nephritis (LN)ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital 12
Testing effectiveness (Phase 2)UnknownNCT02123615
What this trial is testing

ASIS for GAMMAGARD in Primary Immunodeficiency

Who this might be right for
Primary Immunodeficiency
ASIS Corporation 60
Early research (Phase 1)Study completedNCT00481117
What this trial is testing

Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 37
Large-scale testing (Phase 3)UnknownNCT05172817
What this trial is testing

Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Study in RA Patients

Who this might be right for
PharmacokineticsSafetyEfficacy+1 more
Institute for Developing Science and Health Initiatives, Bangladesh 200
Post-approval studies (Phase 4)UnknownNCT01574508
What this trial is testing

Continuous Subcutaneous Insulin Infusion strAtegy Versus Multiple Daily Insulin Injections strAtegy

Who this might be right for
Type 2 Diabetes
Shanghai Jiao Tong University School of Medicine 120
Early research (Phase 1)Looking for participantsNCT06830031
What this trial is testing

Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell-lymphomaDLBCL, Nos Genetic SubtypesFollicular Lymphoma Grade 3B+3 more
Shanghai Exuma Biotechnology Ltd. 18
Post-approval studies (Phase 4)Study completedNCT02503293
What this trial is testing

Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push

Who this might be right for
Primary Immunodeficiency
Octapharma 30
Testing effectiveness (Phase 2)WithdrawnNCT00661921
What this trial is testing

Double Blind, Placebo Controlled Trial With AMG 108 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Amgen
Large-scale testing (Phase 3)UnknownNCT03860688
What this trial is testing

Effects of Oral Glucose and Teduglutide on Plasma Lipoproteins

Who this might be right for
Hyperlipidemias
University Health Network, Toronto 15
Early research (Phase 1)Study completedNCT06929039
What this trial is testing

Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy Subjects

Who this might be right for
Rheumatoid Arthritis (RA
Kashiv BioSciences, LLC 300
Testing effectiveness (Phase 2)Temporarily pausedNCT07530705
What this trial is testing

Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult Hypoparathyroidism

Who this might be right for
Hypoparathyroidism
Peking Union Medical College Hospital 15
Early research (Phase 1)Active Not RecruitingNCT07791342
What this trial is testing

A Phase I Study of 9MW4113 Injection Versus Dupixent®

Who this might be right for
Healthy Participants
Mabwell (Shanghai) Bioscience Co., Ltd. 208
Early research (Phase 1)Active Not RecruitingNCT07535775
What this trial is testing

Evaluate Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 After Single Subcutaneous Injection in Healthy Chinese Volunteers

Who this might be right for
Healthy Adult Participants
SPH-BIOCAD (HK) Limited 48
Testing effectiveness (Phase 2)Ended earlyNCT00119600
What this trial is testing

AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy

Who this might be right for
AnemiaCancer
Amgen
Early research (Phase 1)Study completedNCT00001112
What this trial is testing

The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT06565273
What this trial is testing

Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd 40
Early research (Phase 1)Study completedNCT01579383
What this trial is testing

Safety Tolerability and Pharmacokinetics of ALD403

Who this might be right for
Migraine Disorders
Alder Biopharmaceuticals, Inc. 104
Early research (Phase 1)Study completedNCT05017012
What this trial is testing

Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)

Who this might be right for
Advanced or Metastatic Solid Tumors
Merck Sharp & Dohme LLC 142
Large-scale testing (Phase 3)UnknownNCT05070364
What this trial is testing

Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV

Who this might be right for
Hepatitis Delta Virus
Eiger BioPharmaceuticals 150
Next Page